Marta Ciszek-Lenda Selected Research

N(1)-methylnicotinamide

2/2016

1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Ciszek-Lenda Research Topics

Disease

3	Inflammation (Inflammations) 01/2021 - 01/2015
3	Infections 01/2021 - 01/2019
2	Experimental Arthritis 05/2020 - 06/2012
2	Arthritis (Polyarthritis) 05/2020 - 06/2012
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Chickenpox 01/2019
1	Infectious Skin Diseases 01/2019
1	Soft Tissue Infections 01/2019
1	Hepatitis 02/2016
1	Colitis 01/2015
1	Peritonitis 01/2015
1	Rheumatoid Arthritis 06/2012

Drug/Important Bio-Agent (IBA)

2	CollagenIBA 05/2020 - 06/2012
2	Immunoglobulin G (IgG)IBA 05/2020 - 06/2012
2	LipopolysaccharidesIBA 05/2020 - 06/2012
2	Ibuprofen (Motrin)FDA LinkGeneric 01/2019 - 01/2019
1	C-Reactive ProteinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Concanavalin AIBA 02/2016
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2016
1	Interleukin-4 (Interleukin 4)IBA 02/2016
1	N(1)-methylnicotinamideIBA 02/2016
1	Trinitrobenzenesulfonic AcidIBA 01/2015
1	AutoantibodiesIBA 06/2012
1	Collagen Type II (Type II Collagen)IBA 06/2012
1	Freund's AdjuvantIBA 06/2012

Therapy/Procedure

2	Therapeutics 01/2019 - 06/2012
1	Intravenous Administration 05/2020
1	Oral Administration 01/2015